• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌感染的复发:发生率及影响因素。

Recurrence of Helicobacter pylori infection: incidence and influential factors.

机构信息

Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China.

出版信息

Chin Med J (Engl). 2019 Apr 5;132(7):765-771. doi: 10.1097/CM9.0000000000000146.

DOI:10.1097/CM9.0000000000000146
PMID:30897591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6595863/
Abstract

BACKGROUND

Helicobacter pylori (H. pylori) eradication has been widely used. The recurrence rate of H. pylori after eradication and its related factors are gaining more and more attention. Our study aimed to determine the recurrence rate of H. pylori infection after successful eradication, and analyze its influential factors.

METHODS

We prospectively studied 1050 patients with upper gastrointestinal symptoms who were diagnosed as H. pylori infection by gastroscopy and underwent eradication therapies from April 2013 to January 2014. The C-urea breath test (UBT) or Warthin-Starry (WS) staining was done at 8 to 12 weeks after the therapy. Patients with successful eradication were followed by repeated UBT or gastroscopy at one year and 3 years after therapy, as well as, questionnaire surveys. Recurrence was considered if the UBTs or WS staining of biopsy were positive. One-year and 3-year recurrence rates were calculated, and analyzed the differences between recurred patients and others in basic data, sociological characteristics, lifestyle.

RESULTS

A total of 743 patients finished the 1-year follow-up, and the 1-year recurrence rate was 1.75%. Of the 607 patients who finished the 3-year follow-up, 28 patients recurred, and the 3-year recurrence rate was 4.61%. Analysis of variance showed that low-income, poor hygiene condition of dining out place, and receiving invasive diagnoses or treatments were significant risk factors for H. pylori infection recurrence. Logistic regression analysis demonstrated that the combination of invasive diagnoses or treatments, the level of income, and the hygiene standard of dining out place were significant and independent influential factors of the recurrence of H. pylori.

CONCLUSIONS

The 1-year and 3-year recurrence rates of H. pylori infection after eradication therapy are 1.75% and 4.61%. Low-income, poor hygiene condition of dining out place, and a combination of invasive diagnoses or treatments are independent risk factors of H. pylori recurrence.

摘要

背景

幽门螺杆菌(H. pylori)的根除已被广泛应用。H. pylori 根除后的复发率及其相关因素越来越受到关注。本研究旨在确定 H. pylori 感染根除后复发的发生率,并分析其影响因素。

方法

我们前瞻性研究了 2013 年 4 月至 2014 年 1 月因上消化道症状行胃镜检查并接受根除治疗的 1050 例 H. pylori 感染患者。治疗后 8-12 周行 C-尿素呼气试验(UBT)或华-史染色检查。成功根除的患者在治疗后 1 年和 3 年分别行 UBT 或胃镜检查,并进行问卷调查。如果活检 UBT 或华-史染色阳性,则认为复发。计算 1 年和 3 年的复发率,并分析复发患者与其他患者在基本资料、社会人口学特征、生活方式方面的差异。

结果

共 743 例患者完成 1 年随访,1 年复发率为 1.75%。607 例完成 3 年随访的患者中,28 例复发,3 年复发率为 4.61%。方差分析显示,低收入、外出就餐卫生条件差、接受有创诊断或治疗是 H. pylori 感染复发的显著危险因素。Logistic 回归分析表明,有创诊断或治疗的联合应用、收入水平和外出就餐卫生标准是 H. pylori 复发的显著独立影响因素。

结论

H. pylori 根除治疗后 1 年和 3 年的复发率分别为 1.75%和 4.61%。低收入、外出就餐卫生条件差、有创诊断或治疗的联合应用是 H. pylori 复发的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f94/6595863/174806c8c2a9/cm9-132-765-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f94/6595863/174806c8c2a9/cm9-132-765-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f94/6595863/174806c8c2a9/cm9-132-765-g001.jpg

相似文献

1
Recurrence of Helicobacter pylori infection: incidence and influential factors.幽门螺杆菌感染的复发:发生率及影响因素。
Chin Med J (Engl). 2019 Apr 5;132(7):765-771. doi: 10.1097/CM9.0000000000000146.
2
Recurrence Rate and Influencing Factors of Helicobacter Pylori Infection After Successful Eradication in Southern Coastal China.中国南方沿海地区幽门螺杆菌感染成功根除后的复发率及影响因素
Int J Gen Med. 2024 Mar 19;17:1039-1046. doi: 10.2147/IJGM.S452348. eCollection 2024.
3
Recurrence of Helicobacter pylori infection and the affecting factors: A follow-up study.幽门螺杆菌感染的复发及其影响因素:一项随访研究。
J Dig Dis. 2017 Jan;18(1):47-55. doi: 10.1111/1751-2980.12440.
4
Long-term re-infection rate after Helicobacter pylori eradication in Bangladeshi adults.孟加拉国成年人幽门螺杆菌根除后的长期再感染率。
Digestion. 2007;75(4):173-6. doi: 10.1159/000107046. Epub 2007 Aug 14.
5
The presence of dental disease can be a risk factor for recurrent Helicobacter pylori infection after eradication therapy: a 3-year follow-up.牙科疾病的存在可能是幽门螺杆菌根除治疗后复发感染的一个风险因素:一项为期3年的随访研究。
Endoscopy. 2007 Nov;39(11):942-7. doi: 10.1055/s-2007-966787. Epub 2007 Sep 21.
6
Helicobacter pylori recurrence after first- and second-line eradication therapy in Korea: the problem of recrudescence or reinfection.韩国一线和二线根除治疗后幽门螺杆菌复发:复发或再感染问题
Helicobacter. 2014 Jun;19(3):202-6. doi: 10.1111/hel.12117. Epub 2014 Mar 11.
7
Follow-up of Helicobacter pylori status by using 13C-urea breath test in nonulcer dyspeptic patients after eradication therapy.根除治疗后使用13C-尿素呼气试验对非溃疡性消化不良患者幽门螺杆菌状态进行随访。
Zhonghua Yi Xue Za Zhi (Taipei). 2001 Jun;64(6):337-42.
8
Incidence of Helicobacter pylori recurrent infection and associated factors in Thailand.泰国幽门螺杆菌复发感染的发生率及相关因素
J Med Assoc Thai. 2007 Jul;90(7):1406-10.
9
The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies.汞合金补牙材料对采用联合、四联及基于左氧氟沙星疗法治疗的患者幽门螺杆菌感染发生率及幽门螺杆菌根除率的影响。
Eur J Gastroenterol Hepatol. 2015 Jul;27(7):769-75. doi: 10.1097/MEG.0000000000000372.
10
Eradication Rate of on the US-Mexico Border Using the Urea Breath Test.使用尿素呼气试验检测美墨边境地区的根除率。
South Med J. 2018 Jan;111(1):51-55. doi: 10.14423/SMJ.0000000000000747.

引用本文的文献

1
The role of probiotic supplementation in reducing recurrence after classic quadruple therapy.补充益生菌在降低经典四联疗法后复发率方面的作用。
Front Pharmacol. 2025 Jul 14;16:1621090. doi: 10.3389/fphar.2025.1621090. eCollection 2025.
2
-targeted AI-driven vaccines: a paradigm shift in gastric cancer prevention.靶向人工智能驱动的疫苗:胃癌预防的范式转变。
Front Immunol. 2024 Nov 28;15:1500921. doi: 10.3389/fimmu.2024.1500921. eCollection 2024.
3
Effect of mouthwash containing poly l-Lysine and glycerol monolaurate on oral relating to biofilm eradication, anti-adhesion, and pro-inflammatory cytokine suppression.

本文引用的文献

1
Systematic review with meta-analysis: the global recurrence rate of Helicobacter pylori.系统评价与荟萃分析:幽门螺杆菌的全球复发率
Aliment Pharmacol Ther. 2017 Nov;46(9):773-779. doi: 10.1111/apt.14319. Epub 2017 Sep 11.
2
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.幽门螺杆菌感染的管理——马斯特里赫特 V/佛罗伦萨共识报告。
Gut. 2017 Jan;66(1):6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.
3
Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial.
含聚-L-赖氨酸和甘油单月桂酸酯的漱口水对口腔生物膜根除、抗黏附及促炎细胞因子抑制的影响。
J Dent Sci. 2024 Jul;19(3):1748-1757. doi: 10.1016/j.jds.2023.10.010. Epub 2023 Oct 21.
4
The global, regional, and national patterns of change in the burden of nonmalignant upper gastrointestinal diseases from 1990 to 2019 and the forecast for the next decade.1990年至2019年非恶性上消化道疾病负担的全球、区域和国家变化模式以及未来十年的预测。
Int J Surg. 2025 Jan 1;111(1):80-92. doi: 10.1097/JS9.0000000000001902.
5
The Efficacy and Safety of Minocycline-Containing Quadruple Therapies Against Infection: A Retrospective Cohort Study.含米诺环素的四联疗法治疗感染的疗效与安全性:一项回顾性队列研究
Infect Drug Resist. 2024 Jun 21;17:2513-2529. doi: 10.2147/IDR.S457618. eCollection 2024.
6
Global H. pylori recurrence, recrudescence, and re-infection status after successful eradication in pediatric patients: a systematic review and meta-analysis.全球儿童幽门螺杆菌成功根除后的复发、再燃和再感染状况:系统评价和荟萃分析。
J Gastroenterol. 2024 Aug;59(8):668-681. doi: 10.1007/s00535-024-02114-x. Epub 2024 May 30.
7
Novel MAXPOWER biological antibacterial liquid for eradicating oral Helicobacter pylori.新型 MAXPOWER 生物抗菌液,根除口腔幽门螺杆菌。
BMC Infect Dis. 2024 May 29;24(1):540. doi: 10.1186/s12879-024-09424-8.
8
Recurrence Rate and Influencing Factors of Helicobacter Pylori Infection After Successful Eradication in Southern Coastal China.中国南方沿海地区幽门螺杆菌感染成功根除后的复发率及影响因素
Int J Gen Med. 2024 Mar 19;17:1039-1046. doi: 10.2147/IJGM.S452348. eCollection 2024.
9
Knowledge and Attitude of Medical Students Towards Helicobacter pylori Infection and Its Prevention and Management: A Study From Riyadh, Saudi Arabia.沙特阿拉伯利雅得医学生对幽门螺杆菌感染及其预防与管理的知识和态度:一项研究
Cureus. 2023 Dec 27;15(12):e51174. doi: 10.7759/cureus.51174. eCollection 2023 Dec.
10
Prediction of recurrence of early gastric carcinoma after endoscopic submucosal dissection.早期胃癌内镜黏膜下剥离术后复发的预测。
Afr Health Sci. 2023 Jun;23(2):283-289. doi: 10.4314/ahs.v23i2.32.
作为幽门螺杆菌初始治疗的个体化治疗与三联加铋剂或联合疗法对比:一项随机试验
Helicobacter. 2016 Apr;21(2):91-9. doi: 10.1111/hel.12242. Epub 2015 Jun 23.
4
Role of dental plaque, saliva and periodontal disease in Helicobacter pylori infection.牙菌斑、唾液和牙周疾病在幽门螺杆菌感染中的作用。
World J Gastroenterol. 2014 May 21;20(19):5639-53. doi: 10.3748/wjg.v20.i19.5639.
5
Helicobacter pylori recurrence after first- and second-line eradication therapy in Korea: the problem of recrudescence or reinfection.韩国一线和二线根除治疗后幽门螺杆菌复发:复发或再感染问题
Helicobacter. 2014 Jun;19(3):202-6. doi: 10.1111/hel.12117. Epub 2014 Mar 11.
6
National rates of Helicobacter pylori recurrence are significantly and inversely correlated with human development index.幽门螺杆菌的复发率与人类发展指数呈显著负相关。
Aliment Pharmacol Ther. 2013 May;37(10):963-8. doi: 10.1111/apt.12293. Epub 2013 Apr 2.
7
Presence of Helicobacter pylori in subgingival plaque of periodontitis patients with and without dyspepsia, detected by polymerase chain reaction and culture.通过聚合酶链反应和培养检测有无消化不良的牙周炎患者龈下菌斑中幽门螺杆菌的存在情况。
J Indian Soc Periodontol. 2012 Jul;16(3):398-403. doi: 10.4103/0972-124X.100919.
8
Effect of periodontal therapy on prevention of gastric Helicobacter pylori recurrence: a systematic review and meta-analysis.牙周治疗对预防胃幽门螺杆菌复发的影响:系统评价和荟萃分析。
J Clin Periodontol. 2012 Dec;39(12):1166-73. doi: 10.1111/jcpe.12015.
9
An epidemiologic study on the correlation between oral Helicobacter pylori and gastric H. pylori.一项关于口腔幽门螺杆菌与胃幽门螺杆菌相关性的流行病学研究。
Curr Microbiol. 2009 May;58(5):449-53. doi: 10.1007/s00284-008-9341-3. Epub 2009 Jan 13.
10
Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome.越南幽门螺杆菌根除治疗的长期随访:再感染与临床结局
Aliment Pharmacol Ther. 2005 Apr 15;21(8):1047-53. doi: 10.1111/j.1365-2036.2005.02408.x.